Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-25 @ 2:51 AM
NCT ID:
NCT06410833
Brief Title:
Belimumab After Rituximab in Resistant Primary Juvenile SS
Official Title:
Effectiveness of Belimumab After Rituximab in Resistant Primary Juvenile Sjogren's Syndrome
Acronym:
BRRPJS
Study:
NCT06410833
Protocol Section:
NCT06410833